[1]
D. E. Peñaloza Daguer et al., “Drug-induced severe cutaneous adverse reactions in a patient after COVID-19 infection. Case report ”, Rev Hosp Ital B.Aires, vol. 43, no. 1, pp. 21–24, Mar. 2023, doi: 10.51987/revhospitalbaires.v43i1.260.